Compare UTI MNC Fund vs Kotak MNC Fund
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.04 | 2.01 |
NAV | ₹389.02 | ₹10.59 |
Fund Started | 01 Aug 2005 | 07 Oct 2024 |
Fund Size | ₹2856.33 Cr | ₹2117.86 Cr |
Exit Load | Exit load of 1% if redeemed less than 1 year | 0.5% for redemption within 90 Days |
Risk
Very High
Very High
Rating
-
-
Min SIP Amount
₹500
₹100
Expense Ratio
2.04
2.01
NAV
₹389.02
₹10.59
Fund Started
01 Aug 2005
07 Oct 2024
Fund Size
₹2856.33 Cr
₹2117.86 Cr
Exit Load
Exit load of 1% if redeemed less than 1 year
0.5% for redemption within 90 Days
1 Year | 2.72% | 2.96% |
3 Year | 13.12% | - |
5 Year | 11.27% | - |
1 Year
2.72%
2.96%
3 Year
13.12%
-
5 Year
11.27%
-
Equity | 96.54% | 99.63% |
Cash | 3.08% | 0.37% |
Equity
96.54%
99.63%
Cash
3.08%
0.37%
Top 10 Holdings |
|
|
Top 10 Holdings
Maruti Suzuki India Ltd. | 8.71% |
Vedanta Ltd. | 4.78% |
Procter & Gamble Health Ltd. | 4.58% |
Nestle India Ltd. | 4.51% |
United Spirits Ltd. | 4.47% |
Hindustan Unilever Ltd. | 4.04% |
Infosys Ltd. | 3.06% |
Britannia Industries Ltd. | 3.04% |
Nippon Life India Asset Management Ltd. | 2.65% |
Gland Pharma Ltd. | 2.56% |
Maruti Suzuki India Ltd. | 9.38% |
Britannia Industries Ltd. | 7.28% |
Hindustan Unilever Ltd. | 6.26% |
Nestle India Ltd. | 3.91% |
Vedanta Ltd. | 3.73% |
Acutaas Chemicals Ltd. | 3.38% |
Ashok Leyland Ltd. | 3.09% |
JB Chemicals & Pharmaceuticals Ltd. | 2.97% |
United Spirits Ltd. | 2.97% |
GE Vernova T&D India Ltd | 2.82% |
Name | - | Harsha Upadhyaya |
Start Date | - | 03 Apr 2025 |
Name
-
Harsha Upadhyaya
Start Date
-
03 Apr 2025
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. | The scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). |
Launch Date | 01 Aug 2005 | 07 Oct 2024 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies.
The scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC).
Launch Date
01 Aug 2005
07 Oct 2024